{"nct_id":"NCT01727141","title":"A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2012-11","start_date_type":null,"primary_completion_date":"2014-02","primary_completion_date_type":"ACTUAL","completion_date":"2014-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}